Zusammenfassung
Viren bestehen aus dem viralen Genom,welches die genetische Information des Virus darstellt und aus DNS oder RNS bestehen kann, und aus der Proteinhülle, dem sog. Capsid. Beide zusammen bilden das Virion (= Viruselementarkörper), welches manchmal noch zusätzlich von einer weiteren Protein- bzw. Lipidhülle umgeben ist. Die Vermehrung von Virionen ist ausschließlich innerhalb lebender Zellen möglich, indem die Zellorganellen von den Virionen für die eigene Vervielfältigung genutzt werden. Dabei können Virusgenome 2 grundsätzlich unterschiedliche Klassen von Proteinen kodieren: Virionproteine und Nichtvirionproteine. Den Nichtvirionproteinen kommt u. a. die Funktion zu, die DNS-Synthese der Gastzelle zu stimulieren; damit tragen sie zum unkontrollierten Wachstum der Zelle bei. Dies ist eine wichtige Voraussetzung für die onkogene Potenz einiger Viren (s. Tabelle 3.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Albrecht G (1986) Condylomata acuminata. Neuere Aspekte zur Klinik, Pathogenese und Therapie. Z Hautkr 61: 457–462
Baker DA, Douglas JM, Buntin DM, et al. (1990) Topical podofilox for the treatment of condylomata acuminata in women. Obstet Gynecol 76: 656–659
Banett M et al. (1990). Feline cowpox virus infection. J Small Animal Proct 31: 167–173
Bauer HM, Ting Y, Greer CE et al. (1991) Genital human papilloma virus infection in female university students as determined by a PCR-based method. JAMA 265: 472–477
Baxby D (1977) Is cowpox misnamed? A review of 10 human cases. Br Med J 1: 1379–1381
Benedetti PP, Scambia G, Baiocchi G et al. (1989) Randomized clinical trial comparing systemic interferon with diathermocoagulation in primary multiple and widespread anogenital condyloma. Obstet Gynecol 74: 393–397
Bernstein JE, Korman NJ, Bickers DR et al. (1989) Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 21: 265–270
Beutner K, Conant M, Friedman-Kien AE (1988) Patient applied podofilox for the treatment of genital warts. Lancet I: 831–834
De Villiers EM (1989) Heterogeneity of the human papilloma group. J Virol 63: 4899–4903
Donofrio P, Walter F, Hust V et al. (1991) Treatment of painful diabetic neuropathy with topical capsaicin. Ann Intern Med 151: 2225–2229
Dunkle LM, Arvin AM, Whitley RJ et al. (1991) Acyclovir treatment of varicella in otherwise healthy children. New Engl J Med 325: 1539–1544
Duus BR, Philipsen T, Christensen JD, Sondergaard J (1985) Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. Genitourin Med 61: 703–707
Erlich KS, Jacobson MA, Koehler JE et al. (1989) Fos-carnet therapy for severe acyclovir-resistant herpes simplex virus type 2-infections in patients with AIDS. Ann Intern Med 110: 710–713
Eron LJ, Judson F, Tucker S, Prawer S (1986) Interferon therapy for condylomata acuminata. N Engl J Med 315: 1059–1064
Erpenbach K, Derschum W, Vietsch H (1990) Adjuvant-systemische interferon-alpha 2b-Behandlung bei therapieresistenten anogenitalen Condylomata acuminata. Urologe 29: 43–45
Ferenczy A, Mitao M, Nagai N et al. (1985) Latent papillomavirus and recurrent genital warts. N Engl J Med 313: 784–788
Greenberg MD, Rutledge LH, Reid R et al. (1991) A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women. Obstet Gynecol 77: 735–739
Gross G (1987) Interferone zur Behandlung von Condylomata acuminata. Dtsch Med Wochenschr 112: 571
Gross G, Ikenberg H, Roussaki A et al. (1986) Systemic treatment of condylomata acuminata with recombinant interferon alpha 2a: low-dose superior to the high-dose regimen. J Chemotherapy 32: 537–541
Gross G, Roussaki A, Pfister H (1988) Die postoperative Interferon-Hydrogel-Behandlung. Hautarzt 39: 684–687
Hohenleutner U, Landthaler M, Braun-Falco O (1990) Postoperative adjuvante Therapie mit Interferonalfa-2b nach Laserchirurgie von Condylomata acuminata. Hautarzt 41: 545–548
Hohenleutner U, Landthaler M, Braun-Falco O et al. (1988) Condylomata acuminata gigantea (BuschkeLöwensteinTumor). Behandlung mit dem CO2Laser und Interferon. Dtsch Med Wochenschr 113: 985–987
Huff CJ, Bean B, Balfour HH et al. (1988) Therapy of herpes zoster with oral acyclovir. Am J Med 85 [Suppl 2A]: 84–88
Kaplowitz LG, Baker D, Gelb L (1991) Prolonged continuous acyclovir treatment of normal adults with fre-quently recurring genital herpes simplex virus infection. JAMA 265: 747–751
Kea S, Tang N, Isenberg M, Storrey B et al. (1988) Topical interferon for treating condyloma acuminata in women. J Infect Dis 158: 934–939
Kraus SJ, Stone KM (1990) Management of genital infection caused by human papillomavirus. Rev Infect Dis 12: 620–632
Krebs H, Wheelock J (1985) The CO2 Laser for recurrent and therapy-resistant condylomata acuminata. J Reproduct Med 30: 489–492
Kryger-Baggesen N, Larsen J, Pedersen P (1984) CO2Laser treatment of condylomata acuminata. Acta Obstet Gynecol Scand 63: 341–343
Landthaler M, Haina D, Brunner R et al. (1986) Laser therapy of bowenoid papulosis and Bowen’s disease. J Dermatol Surg Oncol 12: 1253–1257
Ling MR (1992) Therapy of genital human papilloma virus infections. Part I: Indications for and justification of therapy. Intern J Dermatol 31: 682–686
Lutzner MA, Blanchet-Bardon C (1985): Epidermodysplasia verruciformis, In: Recent development in clinical research. Orfanos CE (Ed.), Karger, Basel, pp. 164–185
McCarthy GM, McCarty DJ (1992) Effect of topical capsaicin in the therapy of painfull osteoarthritis of the hands. J Rheumatol 19: 604–607
Mindel A, Faherty A, Carney O et al. (1988) Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet I: 926–928
Olsen EA, Kelly FF, Vollmer RT et al. (1989) Comparative study of systemic interferon alfa-Nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol 20: 1023–1030
Perrillo RP, Schiff ER, Davis GL et al. (1990) A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323: 295–301
Petersen CS, Bjerring P, Larsen J et al. (1991) Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study. Genitourin Med 67: 99–102
Raynor HC, Atkins RL, Westermann RA (1989) Relief of local stump pain by capsaicin cream. Lancet II: 1276–1277
Reichman RC, Oakes D, Bonnez W (1988) Treatment of condyloma acuminatum with three different inter-ferons administered intralesionally; a double-blind, placebo controlled trial. Ann Intern Med 108: 675–679
Reichman RC, Oakes D, Bonnez W et al. (1990) Treatment of condylomata acuminata with three different alpha-interferon preparations administered parenterally: a double-blind, placebo-controlled trial. J Infect Dis 162: 1270–1276
Reid R, Greenberg MG, Pizzuti DJ et al. (1990) Superficial laser vulvectomy. IV. Extended laser vaporiza-tion and adjunctive 5-fluorouracil therapy of human papillomavirus-associated vulvar disease. Obstet Gynecol 76: 439–118
Straus SE, Croen KD, Sawyer MH et al. (1988) Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment. JAMA 260: 2227–2230
Tiedemann KH, Ernst TM (1988) Kombinationstherapie von rezidivierenden Condylomata acuminata mit Elektrokaustik und Alpha-2-Interferon. Akt Derma-toi 14: 200–204
Vance JC, Bart BJ, Hansen RC et al. (1986) Intrale- sional recombinant alpha-2 interferon for treatment of patients with condyloma acuminatum or verruca plantaris. Arch Dermatol 122: 273–277
Zachariae H, Larsen PM, Sogaard PM (1988) Recombinant interferon alpha-2a (Roferon-A) in a case of Buschke-Löwenstein giant condyloma. Dermatologica 177: 175–179
Zur Hausen H (1991) Human papilloma viruses in the pathogenesis of anogenital cancer. Virology 184: 9–13
Zwiorek L, Schmidt-Rhode P, Schulz KD (1989) Interferon in der Behandlung von condylomata acuminata. Geburtshilfe Frauenheilkd 49: 1001–1005
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Orfanos, C.E., Garbe, C. (1995). Viruskrankheiten der Haut und Schleimhaut. In: Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97602-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-97602-5_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97603-2
Online ISBN: 978-3-642-97602-5
eBook Packages: Springer Book Archive